TABLE 6

Kinetic constants (derived from the curves in Figs. 58)

SubstrateEnzyme SourceVmaxKm, Ks, or S50KsiHβR2
nmol · mg1 · min1μM
4-MU1A9-XHCa7.5 ± 0.23.5 ± 0.3220 ± 200.99
1A9-TLa3.7 ± 0.12.9 ± 0.2261 ± 200.99
2B7-XHAb2.6 ± 0.1c381 ± 341.3 ± 0.10.99
2B7-TLb3.2 ± 0.1c293 ± 251.3 ± 0.10.99
Entacapone1A9-XHCd84 ± 313.0 ± 1.00.30 ± 0.020.99
1A9-TLd40 ± 28.0 ± 0.90.30 ± 0.020.97
HLMd51 ± 26.6 ± 0.50.27 ± 0.020.98
AZT2B7-Hise0.07 ± 0.001c216 ± 100.99
2B7-XHAa0.33 ± 0.01c186 ± 30.99
2B7-TLe0.37 ± 0.01c135 ± 40.99
HLMe0.64 ± 0.01117 ± 40.99
  • a Data were fitted to the Substrate inhibition model (eq. 2).

  • b Data were fitted to sigmoid kinetics (Hill equation) (eq. 3).

  • c Normalization of the Vmax values for relative expression level was only possible in part of the samples.

  • d Data were fitted to the two-sites inhibition model (eq. 4).

  • e Data were fitted to the Michaelis-Menten model (eq. 1).